ECH1 and metabolic dysfunction-associated steatohepatitis: Enoyl coenzyme A hydratase 1 (ECH1) treatment in the MCD-induced NASH mice was confirmed to mitigate hepatic steatosis and liver damage by blocking ferroptosis (112).